Bard® Fluoro-4™ Silicone Ureteral Stent 233724Recalls & reported problems
C. R. Bard, Inc. · Bard® Fluoro-4™ Silicone Ureteral Stent with Hydro-Glide™ Guidewire · Class 2 · Implant
All models of Bard Fluoro-4 Silicone Ureteral Stent (5)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 10801741011716), received between Nov 9, 2021 and Apr 8, 2022 — classified as 1 injury, 4 malfunctions.
The most frequently reported specific device problem is “Calcified” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Calcified1
- Device Dislodged or Dislocated1
- Illegible Information1
- Material Fragmentation1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
- Post Operative Wound Infection1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 8, 2022Illegible Information; Illegible Information
IT WAS REPORTED THAT CUSTOMER STATED THAT THE STENT HAD ENCRUSTATION. ALSO, THE PATIENT HAD SURGICAL SITE INFECTION AND STENT DISLODGMENT. PATIENT ASKED WHY TO BELIEVE THE INFORMATION IN THE INSTRUCTIONS FOR USE (IFU) THAT DID NOT PROVIDE SUFFICIENT INFORMATION ABOUT THE PRODUCT AND ITS MEDICAL APPLICATION WHEN THEY WERE ASKED OF THE COMPLICATIONS WHILE USING THE URETHRAL STENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14054781 ↗MalfunctionApr 8, 2022Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT CUSTOMER STATED THAT THE STENT HAD ENCRUSTATION. ALSO, THE PATIENT HAD SURGICAL SITE INFECTION AND STENT DISLODGMENT. PATIENT ASKED WHY TO BELIEVE THE INFORMATION IN THE INSTRUCTIONS FOR USE (IFU) THAT DID NOT PROVIDE SUFFICIENT INFORMATION ABOUT THE PRODUCT AND ITS MEDICAL APPLICATION WHEN THEY WERE ASKED OF THE COMPLICATIONS WHILE USING THE URETHRAL STENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14051890 ↗InjuryApr 7, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT CUSTOMER STATED THAT THE STENT HAD ENCRUSTATION. ALSO, THE PATIENT HAD SURGICAL SITE INFECTION AND STENT DISLODGMENT. PATIENT ASKED WHY TO BELIEVE THE INFORMATION IN THE INSTRUCTIONS FOR USE (IFU) THAT DID NOT PROVIDE SUFFICIENT INFORMATION ABOUT THE PRODUCT AND ITS MEDICAL APPLICATION WHEN THEY WERE ASKED OF THE COMPLICATIONS WHILE USING THE URETHRAL STENT. MEDICAL INTERVENTION WAS UNKNOWN.
Patient problems: Post Operative Wound Infection
MAUDE report 14046119 ↗MalfunctionApr 7, 2022Calcified; Calcified
IT WAS REPORTED THAT THE CUSTOMER STATED THAT THE STENT HAD ENCRUSTATION. ALSO, THE PATIENT HAD SURGICAL SITE INFECTION AND STENT DISLODGMENT. PATIENT ASKED WHY TO BELIEVE THE INFORMATION IN THE INSTRUCTIONS FOR USE (IFU) THAT DID NOT PROVIDE SUFFICIENT INFORMATION ABOUT THE PRODUCT AND ITS MEDICAL APPLICATION WHEN THEY WERE ASKED ABOUT THE COMPLICATIONS WHILE USING THE URETHRAL STENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14045344 ↗MalfunctionNov 9, 2021Material Fragmentation; Material Fragmentation
IT WAS REPORTED THAT THE URETERAL STENT WAS BROKEN INTO THREE PIECES DURING REMOVAL. THE DEVICE WAS IMPLANTED ON (B)(6) 2021 AND REMOVED ON (B)(6) 2021.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12782465 ↗
Other STENT, URETERAL devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page